Analog Devices Appoints Yoky Matsuoka to its Board of Directors
WILMINGTON, Mass., Jan. 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced the appointment of Dr. Yoky Matsuoka to...
WILMINGTON, Mass., Jan. 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced the appointment of Dr. Yoky Matsuoka to...
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it...
Ignites 2026 with new ski-focused series from Dr. Tom LankeringNEW BERN, N.C., Jan. 22, 2026 /PRNewswire/ -- BrainTap, the leading provider...
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new Orion cortical stimulation...
Investigational ARC-BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement...
Panelists include leaders in the fields of science, medicine and technology: Jack Hidary, Dr. Edward Neilan, Dr. Shoshana Shendelman, Dr....
New draft policy from Highmark Blue Cross Blue Shield extends to both adolescent and adult depression patientsBURLINGTON, Mass. and JERUSALEM,...
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu...
Series B financing will support Exciva's Phase 2 clinical trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's...
CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading global contract research organization (CRO) specialising...
Expanding adoption, evidence, and innovation to support earlier identification and intervention across care and researchBOSTON, Jan. 16, 2026 /PRNewswire/ --...
Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --...
Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --...
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement...
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system...
NEWPORT BEACH, Calif., Jan. 13, 2026 /PRNewswire/ -- Cognoa and The Ability Center today announced the exclusive availability in Saudi...
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the...
DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional...